ArticleFrontiers in public health2023

Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model.

Mingye Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.